127 related articles for article (PubMed ID: 12163847)
21. Steroid hormone interactions with target cells: cross talk between membrane and nuclear pathways.
Farach-Carson MC; Davis PJ
J Pharmacol Exp Ther; 2003 Dec; 307(3):839-45. PubMed ID: 14534365
[TBL] [Abstract][Full Text] [Related]
22. Biologic basis of sequential and combination therapies for hormone-responsive breast cancer.
Pietras RJ
Oncologist; 2006; 11(7):704-17. PubMed ID: 16880230
[TBL] [Abstract][Full Text] [Related]
23. Estrogen signaling and prediction of endocrine therapy.
Hayashi S; Yamaguchi Y
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():27-31. PubMed ID: 16273356
[TBL] [Abstract][Full Text] [Related]
24. Tamoxifen: 28-day oral toxicity study in the rat based on the Enhanced OECD Test Guideline 407 to detect endocrine effects.
Kennel P; Pallen C; Barale-Thomas E; Espuña G; Bars R
Arch Toxicol; 2003 Sep; 77(9):487-99. PubMed ID: 12802581
[TBL] [Abstract][Full Text] [Related]
25. Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics.
Dai Q; Franke AA; Yu H; Shu XO; Jin F; Hebert JR; Custer LJ; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):497-502. PubMed ID: 12814993
[TBL] [Abstract][Full Text] [Related]
26. Psychooncology and cancer progression-related alterations of pleasure-associated neurochemical system: Abnormal neuroendocrine response to apomorphine in advanced cancer patients.
Lissoni P; Malugani F; Manganini V; Ardizzoia A; Gardani G; Bartolacelli E; Messina G; Tancini G
Neuro Endocrinol Lett; 2003; 24(1-2):50-3. PubMed ID: 12743532
[TBL] [Abstract][Full Text] [Related]
27. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
28. Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity?
Lam-Tse WK; Lernmark A; Drexhage HA
Springer Semin Immunopathol; 2002 Dec; 24(3):297-321. PubMed ID: 12503056
[TBL] [Abstract][Full Text] [Related]
29. Endocrine disrupters: a human risk?
Waring RH; Harris RM
Mol Cell Endocrinol; 2005 Dec; 244(1-2):2-9. PubMed ID: 16271281
[TBL] [Abstract][Full Text] [Related]
30. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
Tubiana M
Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
[TBL] [Abstract][Full Text] [Related]
31. Estrogen and its receptors in cancer.
Chen GG; Zeng Q; Tse GM
Med Res Rev; 2008 Nov; 28(6):954-74. PubMed ID: 18642351
[TBL] [Abstract][Full Text] [Related]
32. Impact of endocrine disruptor chemicals in gynaecology.
Caserta D; Maranghi L; Mantovani A; Marci R; Maranghi F; Moscarini M
Hum Reprod Update; 2008; 14(1):59-72. PubMed ID: 18070835
[TBL] [Abstract][Full Text] [Related]
33. Thyroid disrupting chemicals: mechanisms and mixtures.
Crofton KM
Int J Androl; 2008 Apr; 31(2):209-23. PubMed ID: 18217984
[TBL] [Abstract][Full Text] [Related]
34. 17 beta-hydroxysteroid dehydrogenases--their role in pathophysiology.
Vihko P; Härkönen P; Soronen P; Törn S; Herrala A; Kurkela R; Pulkka A; Oduwole O; Isomaa V
Mol Cell Endocrinol; 2004 Feb; 215(1-2):83-8. PubMed ID: 15026178
[TBL] [Abstract][Full Text] [Related]
35. Translational research in hormone-related cancer.
Massimo LM; Tonini GP
Ann N Y Acad Sci; 2009 Feb; 1155():1-3. PubMed ID: 19250186
[TBL] [Abstract][Full Text] [Related]
36. New approaches to reverse resistance to hormonal therapy in human breast cancer.
Weinberg OK; Marquez-Garban DC; Pietras RJ
Drug Resist Updat; 2005 Aug; 8(4):219-33. PubMed ID: 16054421
[TBL] [Abstract][Full Text] [Related]
37. [The functional organization of the adaptive and compensatory reactions of the endocrine glands].
Reznikov OH
Fiziol Zh (1994); 1994; 40(5-6):121-7. PubMed ID: 8521983
[TBL] [Abstract][Full Text] [Related]
38. [New aspects of endocrine regulation].
Ahrén B
Lakartidningen; 1981 Mar; 78(12):1197-200. PubMed ID: 7225180
[No Abstract] [Full Text] [Related]
39. Cancer as an endocrine problem.
Holly JM; Perks CM
Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):539-50. PubMed ID: 18971117
[TBL] [Abstract][Full Text] [Related]
40. Human skin: an independent peripheral endocrine organ.
Zouboulis CC
Horm Res; 2000; 54(5-6):230-42. PubMed ID: 11595811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
